These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19926620)

  • 41. The Amplatzer vascular plug and Amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease.
    Schwartz M; Glatz AC; Rome JJ; Gillespie MJ
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):411-7. PubMed ID: 20552654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter closure of persistent ductus arteriosus in adults.
    Bentham JR; Thomson JD; Gibbs JL
    J Interv Cardiol; 2012 Oct; 25(5):501-4. PubMed ID: 22672406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ductal spasm during performance of transcatheter ductal occlusion.
    Batlivala SP; Glatz AC; Gillespie MJ; Dori Y; Rome JJ
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):762-7. PubMed ID: 23832584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent transcatheter therapy of valvar aortic stenosis and patent ductus arteriosus.
    Samraj R; Rao PS
    J Invasive Cardiol; 2011 Apr; 23(4):E72-5. PubMed ID: 21474856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous closure of hypertensive ductus arteriosus.
    Zabal C; García-Montes JA; Buendía-Hernández A; Calderón-Colmenero J; Patiño-Bahena E; Juanico-Enriquez A; Attie F
    Heart; 2010 Apr; 96(8):625-9. PubMed ID: 20357390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Amplatzer Duct Occluder II: a new device for percutaneous ductus arteriosus closure.
    Saliba Z; El-Rassi I; Abi-Warde MT; Chehab G; Daou L; Khater D; Gerbaka B; Jebara V
    J Interv Cardiol; 2009 Dec; 22(6):496-502. PubMed ID: 19780890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The patent ductus arteriosus-multiple defects and a moving target.
    Mullins CE
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):703-4. PubMed ID: 20976751
    [No Abstract]   [Full Text] [Related]  

  • 48. [Heart rate variability, adrenomedullin and B-type natriuretic peptide before and after transcatheter closure in children with patent ductus arteriosus].
    Wu RZ; Rong X; Ren Y; He XX; Xiang RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):334-6. PubMed ID: 20654079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patent ductus arteriosus at low and high altitudes: anatomical and haemodynamic features and their implications for transcatheter closure.
    Białkowski J; Głowacki J; Zabal C; Garcia-Montes A; Bermudez-Canete R; Flores-Arizmendi R; Sagado-Sandova A; Diaz de Leon H; Delagadillo RM; Kreutzer J
    Kardiol Pol; 2011; 69(5):431-6. PubMed ID: 21594824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcatheter closure of the arterial duct without arterial access.
    Willcoxson FE; Viswanathan S; Thomson JD; Gibbs JL
    Cardiol Young; 2010 Feb; 20(1):39-43. PubMed ID: 20350335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful closure for a case of congenital coronary artery fistula using a patent ductus arteriosus occluder.
    Zhao G; Jin H; Wu H
    Cardiol Young; 2011 Feb; 21(1):97-100. PubMed ID: 20977820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patent ductus arteriosus.
    Anilkumar M
    Cardiol Clin; 2013 Aug; 31(3):417-30. PubMed ID: 23931103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Unexpected occluder dislocation after transcatheter closure of patent ductus arteriosus in two patients].
    Liu ZJ; Shen XQ; Zhao YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):941-2. PubMed ID: 20137551
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety and Efficacy of Transcatheter Closure of Patent Ductus Arteriosus With Severe Mitral Regurgitation in Adults.
    Wang Z; Chen T; Chen L; Qin Y; Zhao X
    J Invasive Cardiol; 2016 Jan; 28(1):30-3. PubMed ID: 26716592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete transcatheter closure of a patent arterial duct with subsequent haemolysis.
    Cace N; Ahel V; Bilic I
    Cardiol Young; 2010 Aug; 20(4):462-4. PubMed ID: 20334722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of Percutaneous Closure of Patent Ductus Arteriosus Accompanied With Unilateral Absence of Pulmonary Artery.
    Yang Y; Zheng H; Xu Z; Zhang G; Jin J; Hu H; Tian T; Zhou X
    Am J Med Sci; 2017 Apr; 353(4):389-393. PubMed ID: 28317628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe thrombocytopenia complicating transcatheter occlusion of a patent ductus arteriosus.
    Zhang P; Zhu XY
    J Invasive Cardiol; 2013 May; 25(5):E88-92. PubMed ID: 23645060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Nano-Film Single-Rivet Patent Ductus Arteriosus Occluders: A Prospective, Randomized and Double-blind Study.
    Shang XK; Liu M; Li HJ; Lu R; Ding SS; Wang B; Dong NG; Chen S
    Curr Med Sci; 2018 Feb; 38(1):85-92. PubMed ID: 30074156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crossing a PDA: the "straightening" technique.
    Jain S; Pinto R; Dalvi B
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):1018-9. PubMed ID: 23804399
    [No Abstract]   [Full Text] [Related]  

  • 60. Simultaneous transcatheter intervention for atrial septal defect complicated with patent ductus arteriosus: A 13-year single institutional retrospective study.
    Wang Q; Zhu X; Wang Z; Cui C; Zhang D; Hou C; Zhang P; Chen H; Meng L
    J Interv Med; 2018 Feb; 1(1):15-21. PubMed ID: 34805826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.